title: Hormone-dependent spinal leiomyoma.
abstract: A 43-year-old woman underwent subtotal removal of a cervical spinal leiomyoma in 1980 and 1981. When her (cyclic) symptoms recurred and tumor growth was demonstrated, she was treated with a synthetic anti-gonadotropic hormone (Danazol; Danatrol) until menopause, when medication could be discontinued without further recurrence of her symptoms or increase in size of the residual tumor.
authors.affiliation: Department of Radiology, Leyenburg Hospital, Den Haag, The Netherlands.
authors.forename: R E
authors.initials: RE
authors.lastname: Hekster
authors.forename: N
authors.initials: N
authors.lastname: Lambooy
authors.forename: E V
authors.initials: EV
authors.lastname: van Hall
authors.forename: B A
authors.initials: BA
authors.lastname: Kazzaz
authors.forename: E J
authors.initials: EJ
authors.lastname: van Rijssel
mesh_terms: D000328:Adult; D002574:Cervical Vertebrae; D003613:Danazol / Q000627:therapeutic use; D004967:Estrogens / Q000502:physiology*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy / Q000503:physiopathology*; D013125:Spinal Neoplasms / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D004967:Estrogens; D003613:Danazol